Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Clovis Oncology Inc (CLVS)

6.7299   -0.25 (-3.58%) 06-03 13:26
Open: 7.05 Pre. Close: 6.98
High: 7.08 Low: 6.71
Volume: 2,975,089 Market Cap: 592M
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.211 - 7.247 7.247 - 7.277
Low: 6.778 - 6.816 6.816 - 6.846
Close: 6.925 - 6.984 6.984 - 7.033

Technical analysis

as of: 2020-06-03 12:56:38 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 10.54     One year: 12.43
Support: Support1: 6.41    Support2: 5.33
Resistance: Resistance1: 9.02    Resistance2: 10.64
Pivot: 7.71
Moving Average: MA(5): 6.99     MA(20): 8.00
MA(100): 7.82     MA(250): 8.19
MACD: MACD(12,26): -0.31     Signal(9): -0.13
Stochastic oscillator: %K(14,3): 13.90     %D(3): 14.59
RSI: RSI(14): 39.90
52-week: High: 17.37  Low: 2.93  Change(%): -53.6
Average Vol(K): 3-Month: 771110  10-Days: 732008

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CLVS has closed above bottom band by 27.7%. Bollinger Bands are 10.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 01 Jun 2020
Investor confidence shakens after Clovis Oncology, Inc. (NASDAQ:CLVS) share prices loss $0 - Marketing Sentinel

Thu, 21 May 2020
Clovis Oncology Needs a Savior - Yahoo Finance

Tue, 02 Jun 2020
Clovis Oncology, Inc. (CLVS): All the Basics You Need to Know - The News Heater

Thu, 14 May 2020
Is Clovis Oncology (CLVS) Stock a Solid Choice Right Now? - Yahoo Finance

Mon, 18 May 2020
Clovis Oncology Announces Proposed Offering of Common Stock - Business Wire

Mon, 01 Jun 2020
Analysts Say You Should Hold Your Position in Clovis Oncology, Inc. (NASDAQ:CLVS) - Stocks Register

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 77
Shares Float (M) 70
% Held by Insiders 2.27
% Held by Institutions 48.46
Shares Short (K) 21,410
Shares Short P. Month (K) 25,120

Stock Financials

EPS -7.060
EPS Est This Year -7.580
EPS Est Next Year -2.460
Book Value (p.s.) -1.730
Profit Margin -271.13
Operating Margin -238.84
Return on Assets (ttm) -32.8
Return on Equity (ttm)
Qtrly Rev. Growth 28.5
Gross Profit (p.s.) 1.470
Sales Per Share 1.982
EBITDA (p.s.) -4.629
Qtrly Earnings Growth
Operating Cash Flow (M) -308
Levered Free Cash Flow (M) -152

Stock Valuations

PE Ratio -0.96
PEG Ratio
Price to Book value -3.93
Price to Sales 3.43
Price to Cash Flow -1.70

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.